Skip to main content
. Author manuscript; available in PMC: 2022 May 26.
Published in final edited form as: Heart. 2022 May 25;108(12):940–947. doi: 10.1136/heartjnl-2021-319597

Table 2.

Characteristics of treatment center treating 1-20 year-old patients in the 12 months around the AVR

Patients with center data Total N=823 R-AVR N=389 (47.3%) M-AVR N=342 (41.6%) T-AVR N=92 (11.2%) p-valuea
Unique centers - N 43 37 40 26
Case volume per 12 mos - Median (IQR) 204 (145-29) 204 (145-304) 206 (145-274) 196 (136-287) 0.55
 Small (10-99) 87 (10.6)b 35 (9.0) 41 (12.0) 11 (12.0)
 Medium (100-199) 314 (38.2) 157 (40.4) 120 (35.1) 37 (40.2) 0.46
 Large (≥ 200) 422 (51.3) 197 (50.6) 181 (52.9) 44 (47.8)
% of high-risk operations – Median (IQR) 9.8(7.7-12.0) 10.3 (8.4-12.3) 9.2 (7.3-11.2) 10.3 (8.0-12.4) <0.01
 <9.4% 377 (45.8) 159 (40.1) 182 (53.2) 36 (39.1) <0.01
 ≥9.4% 446 (54.2) 230 (59.1) 160 (46.8) 56 (60.9)
High risk postoperative mortality - Median (IQR) 2.4(1.4 – 3.5) 2.3 (1.3 – 3.5) 2.5 (1.5 – 3.7) 2.2 (1.1 – 3.4) 0.11
 Cases in centers <3.8% mortality 646 (78.5) 311 (80.0) 261 (76.3) 74 (80.4) 0.44
 Cases in centers ≥3.8% mortality 177 (21.5) 78 (20.1) 81 (23.7) 18 (19.6)
a

p-values comparing the distribution of categorical characteristics across valve types were estimated using chi-squared and the Kruskal-Wallis test was used for continuous factors since normality was not assumed

b

Numbers indicate the count (column percent) unless otherwise specified